Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of HES4 mRNA | CTD | PMID:20106945 | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with TGFB1 protein] results in decreased expression of HES4 mRNA | CTD | PMID:30165855 | 2-palmitoylglycerol | increases expression | EXP | | 6480464 | 2-palmitoylglycerol results in increased expression of HES4 mRNA | CTD | PMID:37199045 | 5-aza-2'-deoxycytidine | affects expression | EXP | | 6480464 | Decitabine affects the expression of HES4 mRNA | CTD | PMID:23300844 | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of HES4 mRNA | CTD | PMID:32763439 | aflatoxin B1 | affects expression | EXP | | 6480464 | Aflatoxin B1 affects the expression of HES4 protein | CTD | PMID:20106945 | aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of HES4 mRNA | CTD | PMID:27153756 | antirheumatic drug | increases expression | EXP | | 6480464 | Antirheumatic Agents results in increased expression of HES4 mRNA | CTD | PMID:24449571 | arsane | multiple interactions | EXP | | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of HES4 mRNA | CTD | PMID:32525701 | arsenic atom | multiple interactions | EXP | | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of HES4 mRNA | CTD | PMID:32525701 | atrazine | increases expression | EXP | | 6480464 | Atrazine results in increased expression of HES4 mRNA | CTD | PMID:22378314 | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of HES4 mRNA | CTD | PMID:20106945 | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of HES4 mRNA | CTD | PMID:32234424 | butan-1-ol | multiple interactions | EXP | | 6480464 | [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of HES4 mRNA | CTD | PMID:29432896 | cadmium atom | increases expression | EXP | | 6480464 | Cadmium results in increased expression of HES4 mRNA | CTD | PMID:24376830 | cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of HES4 mRNA | CTD | PMID:26472689 | cisplatin | affects expression | EXP | | 6480464 | Cisplatin affects the expression of HES4 mRNA | CTD | PMID:23300844 | cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of HES4 mRNA | CTD | PMID:27392435 | cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of HES4 mRNA | CTD | PMID:27392435 | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of HES4 mRNA | CTD | PMID:20106945 and PMID:25562108 | diazinon | increases methylation | EXP | | 6480464 | Diazinon results in increased methylation of HES4 gene | CTD | PMID:22964155 | doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of HES4 mRNA | CTD | PMID:29803840 | fulvestrant | increases methylation | EXP | | 6480464 | Fulvestrant results in increased methylation of HES4 gene | CTD | PMID:31601247 | lipopolysaccharide | multiple interactions | EXP | | 6480464 | S-(1 and 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of HES4 mRNA] | CTD | PMID:35811015 | lipopolysaccharide | increases expression | EXP | | 6480464 | Lipopolysaccharides results in increased expression of HES4 mRNA | CTD | PMID:35811015 | malathion | increases expression | EXP | | 6480464 | Malathion results in increased expression of HES4 mRNA | CTD | PMID:37047231 | N-methyl-4-phenylpyridinium | increases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of HES4 mRNA | CTD | PMID:24810058 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of HES4 mRNA | CTD | PMID:21420995 and PMID:29067470 | quercetin | increases expression | EXP | | 6480464 | Quercetin results in increased expression of HES4 mRNA | CTD | PMID:21632981 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | EXP | | 6480464 | S-(1 and 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of HES4 mRNA] | CTD | PMID:35811015 | sodium arsenate | multiple interactions | EXP | | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of HES4 mRNA | CTD | PMID:32525701 | temozolomide | increases expression | EXP | | 6480464 | Temozolomide results in increased expression of HES4 mRNA | CTD | PMID:31758290 | trichostatin A | increases expression | EXP | | 6480464 | trichostatin A results in increased expression of HES4 mRNA | CTD | PMID:24935251 | triclosan | decreases expression | EXP | | 6480464 | Triclosan results in decreased expression of HES4 mRNA | CTD | PMID:30510588 | urethane | decreases expression | EXP | | 6480464 | Urethane results in decreased expression of HES4 mRNA | CTD | PMID:28818685 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of HES4 mRNA | CTD | PMID:25979313 | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of HES4 gene | CTD | PMID:29154799 | zinc atom | multiple interactions | EXP | | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of HES4 mRNA | CTD | PMID:18593933 | zinc(0) | multiple interactions | EXP | | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of HES4 mRNA | CTD | PMID:18593933 | zoledronic acid | decreases expression | EXP | | 6480464 | zoledronic acid results in decreased expression of HES4 mRNA | CTD | PMID:24714768 | |